Selected research
Industry Growth & Trends
Global Polymers Drug Delivery Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Polymers Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Polymers Drug Delivery market include Eisai, Sanofi, Johnson & Johnson, Vectura Group Plc, Tolmar, SurModics, Quark Pharmaceuticals Inc, Perrigo and Nektar Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Polymers Drug Delivery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Polymers Drug Delivery market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Polymers Drug Delivery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Polymers Drug Delivery.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Polymers Drug Delivery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Polymers Drug Delivery Market by Company
Eisai
Sanofi
Johnson & Johnson
Vectura Group Plc
Tolmar
SurModics
Quark Pharmaceuticals Inc
Perrigo
Nektar Therapeutics
Janssen Biotech
Inovio Pharmaceuticals
Heron
Gilead Sciences
Enzon Pharmaceuticals
EnColl Corporation
Allergan
Alkermes
Polymers Drug Delivery Segment by Type
Micelles
Dendrimer
Hydrogels
Microgels
Other
Polymers Drug Delivery Segment by Application
Medical Research Center
Pharmaceutical Factory
Other
Polymers Drug Delivery Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymers Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymers Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymers Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Polymers Drug Delivery companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Micelles
- Dendrimer
- Hydrogels
- Microgels
- Other
Applications
- Medical Research Center
- Pharmaceutical Factory
- Other
Companies covered
- Eisai
- Sanofi
- Johnson & Johnson
- Vectura Group Plc
- Tolmar
- SurModics
- Quark Pharmaceuticals Inc
- Perrigo
- Nektar Therapeutics
- Janssen Biotech
- Inovio Pharmaceuticals
- Heron
- Gilead Sciences
- Enzon Pharmaceuticals
- EnColl Corporation
- Allergan
- Alkermes
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Polymers Drug Delivery Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Polymers Drug Delivery Market Size by Region (2021-2032)
- 1.4.1 Global Polymers Drug Delivery Market Size by Region (2021-2026)
- 1.4.2 Global Polymers Drug Delivery Market Size by Region (2027-2032)
- 1.5 Key Regions Polymers Drug Delivery Market Size (2021-2032)
- 1.5.1 North America Polymers Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Polymers Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Polymers Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.4 South America Polymers Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Polymers Drug Delivery Market Size Growth Rate (2021-2032)
2 Polymers Drug Delivery Market by Type
- 2.1 Type Introduction
- 2.1.1 Micelles
- 2.1.2 Dendrimer
- 2.1.3 Hydrogels
- 2.1.4 Microgels
- 2.1.5 Other
- 2.2 Global Polymers Drug Delivery Market Size by Type
- 2.2.1 Global Polymers Drug Delivery Market Size Overview by Type (2021-2032)
- 2.2.2 Global Polymers Drug Delivery Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Polymers Drug Delivery Market Size Forecasted by Type (2027-2032)
- 2.3 Global Polymers Drug Delivery Market Size by Regions
- 2.3.1 North America Polymers Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Polymers Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Polymers Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Polymers Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Polymers Drug Delivery Market Size Breakdown by Type (2021-2026)
3 Polymers Drug Delivery Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Research Center
- 3.1.2 Pharmaceutical Factory
- 3.1.3 Other
- 3.2 Global Polymers Drug Delivery Market Size by Application
- 3.2.1 Global Polymers Drug Delivery Market Size Overview by Application (2021-2032)
- 3.2.2 Global Polymers Drug Delivery Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Polymers Drug Delivery Market Size Forecasted by Application (2027-2032)
- 3.3 Global Polymers Drug Delivery Market Size by Regions
- 3.3.1 North America Polymers Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Polymers Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Polymers Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Polymers Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Polymers Drug Delivery Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Polymers Drug Delivery Industry Trends
- 4.2 Polymers Drug Delivery Industry Drivers
- 4.3 Polymers Drug Delivery Industry Opportunities and Challenges
- 4.4 Polymers Drug Delivery Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Polymers Drug Delivery Revenue (2021-2026)
- 5.2 Global Polymers Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Polymers Drug Delivery Key Company Headquarters & Area Served
- 5.4 Global Polymers Drug Delivery Company, Product Type & Application
- 5.5 Global Polymers Drug Delivery Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Polymers Drug Delivery Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Polymers Drug Delivery Players Market Share by Revenue in 2025
- 5.6.3 2025 Polymers Drug Delivery Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Eisai
- 6.1.1 Eisai Company Information
- 6.1.2 Eisai Business Overview
- 6.1.3 Eisai Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Eisai Polymers Drug Delivery Product Portfolio
- 6.1.5 Eisai Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sanofi Polymers Drug Delivery Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Johnson & Johnson Polymers Drug Delivery Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Vectura Group Plc
- 6.4.1 Vectura Group Plc Company Information
- 6.4.2 Vectura Group Plc Business Overview
- 6.4.3 Vectura Group Plc Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Vectura Group Plc Polymers Drug Delivery Product Portfolio
- 6.4.5 Vectura Group Plc Recent Developments
- 6.5 Tolmar
- 6.5.1 Tolmar Company Information
- 6.5.2 Tolmar Business Overview
- 6.5.3 Tolmar Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tolmar Polymers Drug Delivery Product Portfolio
- 6.5.5 Tolmar Recent Developments
- 6.6 SurModics
- 6.6.1 SurModics Company Information
- 6.6.2 SurModics Business Overview
- 6.6.3 SurModics Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 SurModics Polymers Drug Delivery Product Portfolio
- 6.6.5 SurModics Recent Developments
- 6.7 Quark Pharmaceuticals Inc
- 6.7.1 Quark Pharmaceuticals Inc Company Information
- 6.7.2 Quark Pharmaceuticals Inc Business Overview
- 6.7.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio
- 6.7.5 Quark Pharmaceuticals Inc Recent Developments
- 6.8 Perrigo
- 6.8.1 Perrigo Company Information
- 6.8.2 Perrigo Business Overview
- 6.8.3 Perrigo Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Perrigo Polymers Drug Delivery Product Portfolio
- 6.8.5 Perrigo Recent Developments
- 6.9 Nektar Therapeutics
- 6.9.1 Nektar Therapeutics Company Information
- 6.9.2 Nektar Therapeutics Business Overview
- 6.9.3 Nektar Therapeutics Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Nektar Therapeutics Polymers Drug Delivery Product Portfolio
- 6.9.5 Nektar Therapeutics Recent Developments
- 6.10 Janssen Biotech
- 6.10.1 Janssen Biotech Company Information
- 6.10.2 Janssen Biotech Business Overview
- 6.10.3 Janssen Biotech Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Janssen Biotech Polymers Drug Delivery Product Portfolio
- 6.10.5 Janssen Biotech Recent Developments
- 6.11 Inovio Pharmaceuticals
- 6.11.1 Inovio Pharmaceuticals Company Information
- 6.11.2 Inovio Pharmaceuticals Business Overview
- 6.11.3 Inovio Pharmaceuticals Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 6.11.5 Inovio Pharmaceuticals Recent Developments
- 6.12 Heron
- 6.12.1 Heron Company Information
- 6.12.2 Heron Business Overview
- 6.12.3 Heron Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Heron Polymers Drug Delivery Product Portfolio
- 6.12.5 Heron Recent Developments
- 6.13 Gilead Sciences
- 6.13.1 Gilead Sciences Company Information
- 6.13.2 Gilead Sciences Business Overview
- 6.13.3 Gilead Sciences Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Gilead Sciences Polymers Drug Delivery Product Portfolio
- 6.13.5 Gilead Sciences Recent Developments
- 6.14 Enzon Pharmaceuticals
- 6.14.1 Enzon Pharmaceuticals Company Information
- 6.14.2 Enzon Pharmaceuticals Business Overview
- 6.14.3 Enzon Pharmaceuticals Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio
- 6.14.5 Enzon Pharmaceuticals Recent Developments
- 6.15 EnColl Corporation
- 6.15.1 EnColl Corporation Company Information
- 6.15.2 EnColl Corporation Business Overview
- 6.15.3 EnColl Corporation Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 EnColl Corporation Polymers Drug Delivery Product Portfolio
- 6.15.5 EnColl Corporation Recent Developments
- 6.16 Allergan
- 6.16.1 Allergan Company Information
- 6.16.2 Allergan Business Overview
- 6.16.3 Allergan Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Allergan Polymers Drug Delivery Product Portfolio
- 6.16.5 Allergan Recent Developments
- 6.17 Alkermes
- 6.17.1 Alkermes Company Information
- 6.17.2 Alkermes Business Overview
- 6.17.3 Alkermes Polymers Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Alkermes Polymers Drug Delivery Product Portfolio
- 6.17.5 Alkermes Recent Developments
7 North America
- 7.1 North America Polymers Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Polymers Drug Delivery Market Size by Country (2021-2026)
- 7.3 North America Polymers Drug Delivery Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Polymers Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Polymers Drug Delivery Market Size by Country (2021-2026)
- 8.3 Europe Polymers Drug Delivery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Polymers Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Polymers Drug Delivery Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Polymers Drug Delivery Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Polymers Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Polymers Drug Delivery Market Size by Country (2021-2026)
- 10.3 South America Polymers Drug Delivery Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Polymers Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Polymers Drug Delivery Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Polymers Drug Delivery Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst